Next Article in Journal
Constituents from Vigna vexillata and Their Anti-Inflammatory Activity
Next Article in Special Issue
Methods for Identification of CA125 from Ovarian Cancer Ascites by High Resolution Mass Spectrometry
Previous Article in Journal
Molecular Dynamic Simulation Insights into the Normal State and Restoration of p53 Function
Open AccessArticle

Effects of Cyclooxygenase Inhibitors in Combination with Taxol on Expression of Cyclin D1 and Ki-67 in a Xenograft Model of Ovarian Carcinoma

Department of Gynecology, Nanjing Medical University of Hangzhou Hospital, 261 Huansha Road, Hangzhou 310006, Zhejiang, China
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2012, 13(8), 9741-9753; https://doi.org/10.3390/ijms13089741
Received: 18 June 2012 / Revised: 22 July 2012 / Accepted: 27 July 2012 / Published: 3 August 2012
(This article belongs to the Special Issue Cancer Molecules in Ovarian Cancer 2012)
The present study was designed to investigate the effects of cyclooxygenase (COX) inhibitors in combination with taxol on the expression of cyclin D1 and Ki-67 in human ovarian SKOV-3 carcinoma cells xenograft-bearing mice. The animals were treated with 100 mg/kg celecoxib (a COX-2 selective inhibitor) alone, 3 mg/kg SC-560 (a COX-1 selective inhibitor) alone by gavage twice a day, 20 mg/kg taxol alone by intraperitoneally (i.p.) once a week, or celecoxib/taxol, SC-560/celecoxib, SC-560/taxol or SC-560/celecoxib/taxol, for three weeks. To test the mechanism of the combination treatment, the index of cell proliferation and expression of cyclin D1 in tumor tissues were determined by immunohistochemistry. The mean tumor volume in the treated groups was significantly lower than control (p < 0.05), and in the three-drug combination group, tumor volume was reduced by 58.27% (p < 0.01); downregulated cell proliferation and cyclin D1 expression were statistically significant compared with those of the control group (both p < 0.01). This study suggests that the effects of COX selective inhibitors on the growth of tumors and decreased cell proliferation in a SKOV-3 cells mouse xenograft model were similar to taxol. The three-drug combination showing a better decreasing tendency in growth-inhibitory effect during the experiment may have been caused by suppressing cyclin D1 expression. View Full-Text
Keywords: ovarian carcinoma; SC-560; celecoxib; taxol; cyclin D1; cell proliferation ovarian carcinoma; SC-560; celecoxib; taxol; cyclin D1; cell proliferation
Show Figures

MDPI and ACS Style

Li, W.; Cai, J.-H.; Zhang, J.; Tang, Y.-X.; Wan, L. Effects of Cyclooxygenase Inhibitors in Combination with Taxol on Expression of Cyclin D1 and Ki-67 in a Xenograft Model of Ovarian Carcinoma. Int. J. Mol. Sci. 2012, 13, 9741-9753. https://doi.org/10.3390/ijms13089741

AMA Style

Li W, Cai J-H, Zhang J, Tang Y-X, Wan L. Effects of Cyclooxygenase Inhibitors in Combination with Taxol on Expression of Cyclin D1 and Ki-67 in a Xenograft Model of Ovarian Carcinoma. International Journal of Molecular Sciences. 2012; 13(8):9741-9753. https://doi.org/10.3390/ijms13089741

Chicago/Turabian Style

Li, Wei; Cai, Jia-Hui; Zhang, Jun; Tang, Yun-Xian; Wan, Liang. 2012. "Effects of Cyclooxygenase Inhibitors in Combination with Taxol on Expression of Cyclin D1 and Ki-67 in a Xenograft Model of Ovarian Carcinoma" Int. J. Mol. Sci. 13, no. 8: 9741-9753. https://doi.org/10.3390/ijms13089741

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Search more from Scilit
 
Search
Back to TopTop